Evidence map›Paper›PMID 40376887›Full record

ArticleMolecular microbiology2025

Heterologous Surface Display Reveals Conserved Complement Inhibition and Functional Diversification of Borrelia burgdorferi Elp Proteins.

Nathan Hill, Lara M Matulina, Cameron MacIntyre, M Amine Hassani, Sheila Thomas, Matteo Luban, Isabelle Ward, Amina Abdalla, John M Leong, Brandon L Garcia and 1 more

Abstract read
In one paragraph

Article in Molecular microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nathan HillMassachusetts General Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.ORCID 0009-0000-9762-4538
Lara M MatulinaDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
Cameron MacIntyreMassachusetts General Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.
M Amine HassaniMassachusetts General Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.
Sheila ThomasDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
Matteo LubanMassachusetts General Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.
Isabelle WardMassachusetts General Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.
Amina AbdallaMassachusetts General Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.
John M LeongDepartment of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, USA.
Brandon L GarciaDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
Jacob E LemieuxMassachusetts General Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts, USA.

Funding

Virulence Mechanisms of Multifunctional Borrelial ProteinsR01AI146930 · NIAID · KANSAS STATE UNIVERSITY · PI GARCIA, BRANDON LEE · 2020 to 2024
$3.6M
Virulence Mechanisms of Multifunctional Borrelial ProteinsR56AI146930 · NIAID · EAST CAROLINA UNIVERSITY · PI GARCIA, BRANDON LEE, SKARE, JON T · 2019 to 2019
$617k
Microbial Determinants of Clinical Heterogeneity in Lyme DiseaseR00AI148604 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LEMIEUX, JACOB ERIC · 2022 to 2023
$500k
Microbial Determinants of Clinical Heterogeneity in Lyme DiseaseK99AI148604 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LEMIEUX, JACOB ERIC · 2020 to 2021
$273k
NIAID NIH HHS K99 AI148604NIAID NIH HHS R00 AI148604NIAID NIH HHS R01 AI146930NIAID NIH HHS R56 AI146930NIH HHS R01-AI146930U.S. Public Health Service K99/R00-AI148604
6 · The paper itself

Abstract

Lyme disease is a tick-borne spirochetosis with diverse clinical manifestations. Genotypic and phenotypic variation among Borrelia burgdorferi strains correlates with variable manifestations of Lyme disease in humans; this diversity is attributed in part to variation in surface-exposed lipoproteins, which are targets of the human antibody response and contribute to tissue adhesion, immune evasion, and other host interactions. Many B. burgdorferi lipoproteins are encoded as multi-copy gene families, such as the OspE/F-like leader peptide (Elp) protein family, which inhibits classical complement activation by binding complement C1s. To characterize Elp allelic variants, we adapted the Pseudomonas syringae ice nucleation protein (INP) system to present B. burgdorferi lipoproteins on the surface of Escherichia coli. Using this system, we identified interactions with classical complement proteins and mapped binding regions, then validated interactions using recombinant proteins and B. burgdorferi surface display. We also discovered a novel potential interaction between Elp proteins and the mammalian basement membrane protein perlecan, thus revealing a bifunctional nature of Elps. Our findings indicate that Elps have undergone functional diversification while maintaining classical complement inhibition mediated by potent and conserved C1s binding and demonstrate that E. coli surface display offers an efficient, cost-effective, and relatively high-throughput approach to characterize B. burgdorferi lipoproteins.

Indexed as

Bacterial Outer Membrane ProteinsBacterial ProteinsBorrelia burgdorferiLipoproteinsComplement System ProteinsEscherichia coliHumansLyme DiseaseProtein BindingPseudomonas syringaeBacterial Outer Membrane ProteinsBacterial ProteinsComplement System ProteinsLipoproteinsBorrelia burgdorferilipoproteinsLyme diseasesurface display

Identifiers

PMID40376887
PMCPMC12242104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.